Raised plasma homocysteine as a risk factor for retinal vascular occlusive disease

BACKGROUND/AIMS A moderately elevated plasma concentration of the sulphur amino acid homocysteine is an independent risk factor for atherosclerotic vascular disease. Many of the risk factors associated with coronary, cerebral, and peripheral atherosclerotic vascular disease are common to retinal vascular occlusive disease but it is unclear whether elevated plasma concentrations of homocysteine are also associated with such disease. This study assessed the relation between retinal vascular occlusive disease and elevated levels of plasma total homocysteine (tHcy). METHODS A retrospective case-control study involving hospital based controls and cases with retinal artery, central retinal vein (including hemiretinal vein), and branch retinal vein occlusions was performed. The relation between elevated tHcy, defined as a level greater than or equal to 12 μmol/l and risk of retinal vascular occlusive disease was examined. RESULTS 87 cases of retinal vascular occlusive disease including 26 cases of retinal artery occlusion, 40 cases with central retinal vein occlusion, and 21 cases of branch retinal vein occlusion were compared with 87 age matched controls. Mean tHcy levels were higher in all disease groups and this difference was significant in patients with retinal artery occlusions (p= 0.032) and patients with central retinal vein occlusion (p=0.0001). When adjusted for known cardiovascular risk factors, tHcy was an independent risk factor for retinal vascular occlusive disease (OR 2.85 (95% CI 1.43–5.68)). CONCLUSIONS Elevated tHcy is an independent risk factor for retinal vascular occlusive disease. Assessment of tHcy may be important in the investigation and management of patients with retinal vascular occlusive disease.

[1]  H. Blom,et al.  Hyperhomocysteinemia and Venous Thrombosis: A Meta-analysis , 1998, Thrombosis and Haemostasis.

[2]  R. Collins,et al.  Can Dietary Supplements with Folic Acid or Vitamin B6 Reduce Cardiovascular Risk? Design of Clinical Trials to Test the Homocysteine Hypothesis of Vascular Disease , 1998, Journal of cardiovascular risk.

[3]  T. Williamson Central retinal vein occlusion: what’s the story? , 1997, The British journal of ophthalmology.

[4]  N. Newman,et al.  Retinal vein occlusion and transient monocular visual loss associated with hyperhomocystinemia. , 1997, American journal of ophthalmology.

[5]  J. Witteman,et al.  Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. , 1997, JAMA.

[6]  P. Mitchell,et al.  Prevalence and associations of retinal vein occlusion in Australia. The Blue Mountains Eye Study. , 1996, Archives of ophthalmology.

[7]  H. Mandel,et al.  Coexistence of hereditary homocystinuria and factor V Leiden--effect on thrombosis. , 1996, The New England journal of medicine.

[8]  P. Reitsma,et al.  Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. , 1996, The New England journal of medicine.

[9]  J. Larsson,et al.  Activated protein C resistance in young adults with central retinal vein occlusion. , 1996, The British journal of ophthalmology.

[10]  T. Williamson,et al.  Blood viscosity, coagulation, and activated protein C resistance in central retinal vein occlusion: a population controlled study. , 1996, The British journal of ophthalmology.

[11]  C. Greven,et al.  Retinal arterial occlusions in young adults. , 1995, American journal of ophthalmology.

[12]  G. Omenn,et al.  A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. , 1995, JAMA.

[13]  R. Dhôte,et al.  Central retinal vein thrombosis associated with resistance to activated protein C. , 1995, American journal of ophthalmology.

[14]  H S Mangat,et al.  Retinal artery occlusion. , 1995, Survey of ophthalmology.

[15]  T. Williamson,et al.  Influence of age, systemic blood pressure, smoking, and blood viscosity on orbital blood velocities. , 1995, The British journal of ophthalmology.

[16]  P. Wilson,et al.  Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. , 1993, JAMA.

[17]  J. Cruysberg,et al.  Hyperhomocysteinemia in retinal artery and retinal vein occlusion. , 1993, American journal of ophthalmology.

[18]  P. Ueland,et al.  Homocysteine and other thiols in plasma and urine: automated determination and sample stability. , 1993, Clinical chemistry.

[19]  F. Verbraak,et al.  Homocystinuria presenting as central retinal artery occlusion and longstanding thromboembolic disease. , 1990, The British journal of ophthalmology.

[20]  C. Forbes,et al.  Abnormal blood viscosity and haemostasis in long-standing retinal vein occlusion. , 1983, The British journal of ophthalmology.

[21]  R. Russell The source of retinal emboli. , 1968, Lancet.

[22]  R. W. Hollenhorst Vascular status of patients who have cholesterol emboli in the retina. , 1966, American journal of ophthalmology.

[23]  D. W. Neill,et al.  Metabolic Abnormalities Detected in a Survey of Mentally Backward Individuals in Northern Ireland , 1962, Archives of disease in childhood.

[24]  E. Herbert Arterial Occlusion , 1952 .

[25]  I. C. Michaelson RETINAL ARTERY OCCLUSION , 1948, The British journal of ophthalmology.

[26]  E. Falk,et al.  Homocysteine and atherothrombosis , 2001, Lipids.

[27]  T. Ciulla,et al.  Retinal arterial occlusions in young adults. , 1996, American journal of ophthalmology.

[28]  Charles R.scriver The Metabolic basis of inherited disease , 1989 .

[29]  K. Mccully Homocysteine theory of arteriosclerosis: development and current status , 1983 .